A bicyclic and hsst2 selective somatostatin analogue: design, synthesis, conformational analysis and binding.
A backbone bridged and disulfide bridged bicyclic somatostatin analogue, compound 1 (PTR-3205), was designed and synthesized by solid-phase methodology. The binding of compound 1 to the five different somatostatin receptors, expressed in CHO or COS-7 cells, indicate a high degree of selectivity towards hsstr2. The three-dimensional structure of this compound has been determined in DMSO-d(6) and in water by 1H NMR and by molecular dynamics simulations. Similar backbone conformations were observed in both solvents. We have established direct evidence that the backbone of this bicyclic somatostatin analogue assumes a 'folded' conformation in solution, where the lactam ring extends roughly in the plane of the beta-turn. The pharmacophoric region Phe-(D)-Trp-Lys-Thr of compound 1 is in accord with that of both the Veber compound L-363,301 (Merck) and sandostatin. We believe that the enhanced selectivity towards the hsst2 receptor, in comparison with other analogues, is due to its large hydrophobic region, composed of the lactam ring and the Phe side chains at positions 1 and 8.
Falb
E
E
Peptor Ltd., Kiryat Weizmann 16, Rehovot 76326, Israel.
Salitra
Y
Y
Yechezkel
T
T
Bracha
M
M
Litman
P
P
Olender
R
R
Rosenfeld
R
R
Senderowitz
H
H
Jiang
S
S
Goodman
M
M
D000818:Animals; D001671:Biochemistry / Q000379:methods; D016466:CHO Cells; D002478:Cells, Cultured; D006224:Cricetinae; D015195:Drug Design; D004353:Drug Evaluation, Preclinical; D009682:Magnetic Resonance Spectroscopy; D008958:Models, Molecular; D015394:Molecular Structure; D011869:Radioligand Assay; D017481:Receptors, Somatostatin / Q000235:genetics / Q000378:metabolism*; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000737:chemistry* / Q000378:metabolism*
C449103:PTR-3205; D017481:Receptors, Somatostatin; D013004:Somatostatin; C093733:somatostatin receptor 2